Neurovascular protection by targeting early blood-brain barrier disruption with neurotrophic factors after ischemia-reperfusion in rats *

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 4, 2013, Pages 557-566

  Pillai, Deepu R ^a,b   Shanbhag, Nagesh C ^a,c   Dittmar, Michael S ^a   Bogdahn, Ulrich ^a   Schlachetzki, Felix ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

blood'brain barrier; epidermal growth factor; ischemia reperfusion injury; magnetic resonance imaging; pigment epithelium derived factor; stroke

Indexed keywords

EPIDERMAL GROWTH FACTOR; NEUROTROPIN; PEPTIDE; PIGMENT EPITHELIUM DERIVED FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN REGION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; MALE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; DISEASE MODELS, ANIMAL; EPIDERMAL GROWTH FACTOR; EYE PROTEINS; MALE; NERVE GROWTH FACTORS; RATS; REPERFUSION INJURY; SERPINS; STROKE; TIME FACTORS;

EID: 84876417600     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.201     Document Type: Article

References (42)

1. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-397.
2. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med 2008; 14: 497-500.
3. Sood RR, Taheri S, Candelario-Jalil E, Estrada EY, Rosenberg GA. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab 2008; 28: 431-438.
4. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002; 8: 963-970.
5. Hefti F. Pharmacology of neurotrophic factors. Annu Rev Pharmacol Toxicol 1997; 37: 239-267.
6. Ekdahl CT, Kokaia Z, Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009; 158: 1021-1029.
7. Simard AR, Rivest S. Role of inflammation in the neurobiology of stem cells. Neuroreport 2004; 15: 2305-2310.
8. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 2006; 37: 1-12.
9. Peng H, Wen TC, Tanaka J, Maeda N, Matsuda S, Desaki J et al. Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia-and free radical-induced injuries. J Cereb Blood Flow Metab 1998; 18: 349-360.
10. Pillai DR, Dittmar MS, Baldaranov D, Heidemann RM, Henning EC, Schuierer G et al. Cerebral ischemia-reperfusion injury in rats-a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab 2009; 29: 1846-1855.
11. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008; 32: 200-219.
12. Pillai DR, Heidemann RM, Kumar P, Shanbhag N, Lanz T, Dittmar MS et al. Comprehensive Small Animal Imaging Strategies on a Clinical 3T Dedicated Head MR-Scanner; Adapted Methods and Sequence Protocols in CNS Pathologies. PLoS One 2011; 6: e16091.
13. Belayev L, Busto R, Zhao W, Ginsberg MD. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 1996; 739: 88-96.
14. Zhang Y, Pardridge WM. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke 2001; 32: 1378-1384.
15. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 2005; 36: 2311-2320.
16. Fisher M. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke 2003; 34: 1539-1546.
17. Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV, Bok D. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci 1995; 15(Part 1): 4992-5003.
18. Taniwaki T, Becerra SP, Chader GJ, Schwartz JP. Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture. J Neurochem 1995; 64: 2509-2517.
19. Sanagi T, Yabe T, Yamada H. Adenoviral gene delivery of pigment epithelium-derived factor protects striatal neurons from quinolinic acid-induced excitotoxi-city. J Neuropathol Exp Neurol 2010; 69: 224-233.
20. Inagaki Y, Yamagishi S, Okamoto T, Takeuchi M, Amano S. Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation. Diabetologia 2003; 46: 284-287.
21. Wang Y, Cooke MJ, Lapitsky Y, Wylie RG, Sachewsky N, Corbett D et al. Transport of epidermal growth factor in the stroke-injured brain. J Control Release 2011; 149: 225-235.
22. Planas AM, Justicia C, Soriano MA, Ferrer I. Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia 1998; 23: 120-129.
23. Zhang Y, Tatsuno T, Carney JM, Mattson MP, Basic FGF. NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cerebral Blood Flow Metab 1993; 13: 378-388.
24. Mattson MP, Lovell MA, Furukawa K, Markesbery WR. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 1995; 65: 1740-1751.
25. Sanagi T, Yabe T, Yamada H. Gene transfer of PEDF attenuates ischemic brain damage in the rat middle cerebral artery occlusion model. J Neurochem 2008; 106: 1841-1854.
26. Jinnouchi Y, Yamagishi S, Matsui T, Takenaka K, Yoshida Y, Nakamura K et al. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice. Brain Res 2007; 1167: 92-100.
27. Ho TC, Yang YC, Cheng HC, Wu AC, Chen SL, Tsao YP. Pigment epithelium-derived factor protects retinal pigment epithelium from oxidant-mediated barrier dysfunction. Biochem Biophys Res Commun 2006; 342: 372-378.
28. Calamante F, Lythgoe MF, Pell GS, Thomas DL, King MD, Busza AL et al. Early changes in water diffusion, perfusion, T1, and T2 during focal cerebral ischemia in the rat studied at 8.5T. Magn Reson Med 1999; 41: 479-485.
29. Allen PS, Castro ME, Treiber EO, Lunt JA, Boisvert DP. A proton NMR relaxation evaluation of a model of brain oedema fluid. Phys Med Biol 1986; 31: 699-711.
30. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 2009; 276: 13-26.
31. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006; 20: 323-325.
32. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-1851.
33. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vasc Pharmacol 2002; 39: 225-237.
34. Liu H, Ren JG, Cooper WL, Hawkins CE, Cowan MR, Tong PY. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Nat Acad Sci USA 2004; 101: 6605-6610.
35. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245-248.
36. Zhang Z, Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 2002; 12: 62-66.
37. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angio-genesis. Nature 2011; 473: 298-307.
38. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM et al. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 2002; 8: 349-357.
39. Ho TC, Chen SL, Yang YC, Liao CL, Cheng HC, Tsao YP. PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc Res 2007; 76: 213-223.
40. Thorne RG, Hrabetova S, Nicholson C. Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging. J Neurophysiol 2004; 92: 3471-3481.
41. Miller AA, Drummond GR, Sobey CG. Reactive oxygen species in the cerebral circulation: are they all bad? Antioxid Redox Signal 2006; 8: 1113-1120.
42. Zheng J, Bird IM, Melsaether AN, Magness RR. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor-and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 1999; 140: 1399-1407.